An Overview of the INDIGO data in French, German, Italian and Spanish An Overview of the INDIGO data in French, German, Italian and Spanish

Vorasidenib is the first targeted therapy with positive pivotal phase 3 data in patients with grade 2 IDH1/2-mutant diffuse glioma. The INDIGO study met primary and key secondary endpoints in the second interim analysis.Medscape Medical Affairs
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None Virtual Symposium Source Type: news